17-5368382-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004703.6(RABEP1):c.1798G>A(p.Val600Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000621 in 1,611,418 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004703.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RABEP1 | NM_004703.6 | c.1798G>A | p.Val600Ile | missense_variant | 12/18 | ENST00000537505.6 | NP_004694.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RABEP1 | ENST00000537505.6 | c.1798G>A | p.Val600Ile | missense_variant | 12/18 | 1 | NM_004703.6 | ENSP00000445408 | P1 | |
ENST00000572792.1 | n.381+2864C>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151322Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249214Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135220
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1460096Hom.: 0 Cov.: 29 AF XY: 0.00000275 AC XY: 2AN XY: 726438
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151322Hom.: 0 Cov.: 32 AF XY: 0.0000407 AC XY: 3AN XY: 73788
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 06, 2022 | The c.1798G>A (p.V600I) alteration is located in exon 12 (coding exon 12) of the RABEP1 gene. This alteration results from a G to A substitution at nucleotide position 1798, causing the valine (V) at amino acid position 600 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at